{"version":"1.0","provider_name":"FYB Financial Yearbook","provider_url":"https:\/\/www.fyb.de\/en\/","author_name":"Tatjana Anderer","author_url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/","title":"DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1RmFlzUGYf\"><a href=\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\">DLA Piper advises Evers sale to Bright Future Pharma Labs<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/embed\/#?secret=1RmFlzUGYf\" width=\"600\" height=\"338\" title=\"&#8220;DLA Piper advises Evers sale to Bright Future Pharma Labs&#8221; &#8212; FYB Financial Yearbook\" data-secret=\"1RmFlzUGYf\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg","thumbnail_width":220,"thumbnail_height":227,"description":"Pinnen\u00adberg \u2014 The phar\u00admaceu\u00adti\u00adcal factory Evers GmbH &amp; Co KG sells to the Chinese company Bright Future Phar\u00admaceu\u00adti\u00adcal Labo\u00adra\u00adto\u00adries Ltd. The company produ\u00adces mainly natu\u00adral medi\u00adci\u00adnes for the urology and gastro\u00aden\u00adte\u00adro\u00adlogy sector, which are sold inter\u00adna\u00adtio\u00adnally and very stron\u00adgly on the Asian market, espe\u00adci\u00adally in Japan and China. The parties have agreed not to disc\u00adlose [&hellip;]"}